Equities
Health CareMedical Equipment and Services
  • Price (USD)146.21
  • Today's Change1.73 / 1.20%
  • Shares traded223.42k
  • 1 Year change-15.31%
  • Beta0.9603
Data delayed at least 15 minutes, as of Mar 28 2024 15:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.

  • Revenue in USD (TTM)2.05bn
  • Net income in USD81.50m
  • Incorporated1996
  • Employees3.80k
  • Location
    Masimo Corp52 DiscoveryIRVINE 92618United StatesUSA
  • Phone+1 (949) 297-7000
  • Fax+1 (949) 297-7499
  • Websitehttps://www.masimo.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Integer Holdings Corp1.60bn90.65m3.84bn10.50k42.882.5220.282.412.682.6847.3045.580.55665.255.15152,064.103.163.283.433.5326.3026.945.686.401.713.540.38980.0016.035.6238.719.3321.71--
Lantheus Holdings Inc1.30bn326.66m4.14bn834.0013.035.0810.723.204.644.6418.5911.910.87239.465.211,554,471.0021.986.6925.757.7363.7153.9025.209.025.451,235.430.40810.0038.6530.441,063.8651.8135.48--
Haemonetics Corporation1.27bn126.57m4.27bn3.03k34.034.5319.413.362.472.4724.8018.570.62292.116.47418,649.006.214.747.055.8953.4849.779.977.411.7625.450.480.0017.675.27166.059.488.06--
Merit Medical Systems Inc1.26bn94.41m4.37bn6.95k46.643.6323.713.481.621.6221.5520.780.63042.367.34180,916.004.732.455.302.7746.4444.507.513.913.959.890.40640.009.247.3326.7015.86-11.16--
Glaukos Corp314.71m-134.66m4.59bn907.00--9.86--14.57-2.78-2.786.509.400.3241.898.29346,980.20-13.86-8.73-14.99-9.3575.9974.77-42.79-28.694.78-28.800.4335--11.2611.66-35.75--14.44--
Novanta Inc881.66m72.88m6.23bn2.90k85.929.2452.147.072.022.0224.4718.800.71473.046.36304,021.405.915.466.746.3445.3643.248.277.711.914.830.34770.002.417.49-1.588.214.19--
Inspire Medical Systems Inc624.80m-21.15m6.47bn1.01k--11.02--10.35-0.7298-0.729821.3219.371.014.228.27618,001.00-3.41-11.27-3.84-12.6084.5484.47-3.39-13.577.17--0.00--53.1965.3252.87--148.37--
DENTSPLY SIRONA Inc3.97bn-132.00m6.91bn15.00k--2.1032.741.74-0.6217-0.621718.6715.890.52823.005.98264,333.30-1.76-1.14-2.13-1.3252.7153.65-3.33-2.510.94673.630.3914--1.10-0.107186.11---4.549.86
Globus Medical Inc1.57bn122.87m7.18bn5.00k45.531.8126.754.581.171.1713.7229.320.4380.95574.38313,695.203.436.903.727.4565.0571.737.8314.052.72--0.09470.0053.3417.08-35.39-4.725.57--
MSA Safety Inc1.79bn58.52m7.60bn5.10k134.917.8963.674.251.431.4345.2124.590.78632.976.04350,518.802.585.083.036.0047.6745.213.287.021.486.070.383665.9117.005.65-67.41-13.664.72-1.10
Masimo Corp2.05bn81.50m7.64bn3.80k95.885.5942.543.731.511.5137.8425.850.65522.005.04538,973.702.618.653.2210.3149.0057.303.9812.031.223.430.3990.000.604219.00-43.21-15.9631.06--
Penumbra Inc1.06bn90.95m8.76bn4.20k97.717.4374.128.282.322.3227.0030.480.72321.045.23252,029.006.212.326.912.6164.4963.908.593.173.49--0.02150.0024.9518.934,643.1668.609.64--
Stevanato Group SpA1.18bn157.66m9.42bn5.64k53.596.8838.818.020.59470.59474.434.630.58183.142.75208,519.407.81--10.81--32.28--13.42--1.0619.740.2593--10.34--1.95------
Henry Schein, Inc.12.34bn416.00m9.66bn25.00k23.852.6614.410.78273.153.1593.6728.281.294.497.47493,560.004.406.097.3110.4431.2930.043.424.400.996310.630.31330.00-2.445.55-22.68-0.145621.27--
Teleflex Inc2.97bn357.57m10.53bn14.50k29.622.3717.573.547.567.5362.8894.410.41142.206.98205,137.204.955.865.396.4255.3755.0412.0214.621.297.780.290115.846.573.97-1.4712.732.510.00
Data as of Mar 28 2024. Currency figures normalised to Masimo Corp's reporting currency: US Dollar USD

Institutional shareholders

54.52%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Dec 20236.29m11.91%
Politan Capital Management LPas of 31 Dec 20234.71m8.92%
The Vanguard Group, Inc.as of 31 Dec 20234.68m8.85%
BlackRock Fund Advisorsas of 31 Dec 20233.96m7.49%
Capital Research & Management Co. (Global Investors)as of 31 Dec 20232.27m4.29%
Massachusetts Financial Services Co.as of 31 Dec 20231.61m3.04%
RTW Investments LPas of 31 Dec 20231.46m2.77%
SSgA Funds Management, Inc.as of 31 Dec 20231.36m2.57%
Farallon Capital Management LLCas of 31 Dec 20231.31m2.48%
T. Rowe Price Investment Management, Inc.as of 31 Dec 20231.16m2.20%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.